ATE357235T1 - Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer - Google Patents

Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer

Info

Publication number
ATE357235T1
ATE357235T1 AT03290092T AT03290092T ATE357235T1 AT E357235 T1 ATE357235 T1 AT E357235T1 AT 03290092 T AT03290092 T AT 03290092T AT 03290092 T AT03290092 T AT 03290092T AT E357235 T1 ATE357235 T1 AT E357235T1
Authority
AT
Austria
Prior art keywords
composition
hydrophilic polymer
bioaequivalent
solid dispersion
dispersion containing
Prior art date
Application number
AT03290092T
Other languages
English (en)
Inventor
Pawan Seth
Original Assignee
Cimex Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32524260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE357235(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cimex Pharma Ag filed Critical Cimex Pharma Ag
Application granted granted Critical
Publication of ATE357235T1 publication Critical patent/ATE357235T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT03290092T 2003-01-14 2003-01-14 Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer ATE357235T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03290092.0A EP1438961B2 (de) 2003-01-14 2003-01-14 Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer

Publications (1)

Publication Number Publication Date
ATE357235T1 true ATE357235T1 (de) 2007-04-15

Family

ID=32524260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03290092T ATE357235T1 (de) 2003-01-14 2003-01-14 Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer

Country Status (7)

Country Link
EP (1) EP1438961B2 (de)
AT (1) ATE357235T1 (de)
DE (1) DE60312636T3 (de)
DK (1) DK1438961T4 (de)
ES (1) ES2283725T5 (de)
PT (1) PT1438961E (de)
SI (1) SI1438961T2 (de)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30929A (en) † 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
EA001219B1 (ru) * 1996-05-20 2000-12-25 Жансен Фармасетика Н.В. Антигрибковые композиции с улучшенной биологической доступностью
FR2758461A1 (fr) † 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
WO1998042318A1 (en) * 1997-03-26 1998-10-01 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
DE69808670T2 (de) * 1997-12-31 2003-07-03 Choongwae Pharma Corp., Seoul/Soul Herstellungsverfahren und zusammensetzung einer oralen zubereitung von itraconazol
JP2002520351A (ja) † 1998-07-17 2002-07-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗菌・カビ剤及びポリマーを被覆したコアを有するペレット
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
KR100694667B1 (ko) † 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
US6673373B2 (en) † 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same

Also Published As

Publication number Publication date
DE60312636T3 (de) 2014-12-24
EP1438961B1 (de) 2007-03-21
SI1438961T1 (sl) 2007-06-30
EP1438961A1 (de) 2004-07-21
DE60312636T2 (de) 2007-12-06
PT1438961E (pt) 2007-05-31
SI1438961T2 (sl) 2014-12-31
ES2283725T5 (es) 2014-11-28
ES2283725T3 (es) 2007-11-01
DK1438961T4 (da) 2014-11-17
DK1438961T3 (da) 2007-07-23
DE60312636D1 (de) 2007-05-03
EP1438961B2 (de) 2014-08-20

Similar Documents

Publication Publication Date Title
DE602004021107D1 (de) Meloxican-formulierungen in nanoteilchenform
BRPI0416239A (pt) método para preparar partìculas de submìcron de paclitaxel
EP1676556A3 (de) Kosmetische Zusammensetzung, die ein Polyorganosiloxan enthält
ATE404600T1 (de) Wasserlösliche blockcopolymere mit einem hydrophilen block und einem hydrophoben block
EA200701997A1 (ru) Композиция из наночастиц бисфосфоната
DE60235411D1 (de) Sterile gefilterte nanoteilchen-formulierungen von budesonid mit tyloxapol als oberflächenstabilisator
ATE433996T1 (de) Humane dr4-antikörper und deren anwendungen
DE602005021777D1 (de) Dentalzusammensetzungen mit nanofüllern und relevante verfahren
WO2007038220A3 (en) Organic-inorganic hybrid particle material and polymer compositions containing same
ATE343376T1 (de) Nanopartikelzusammensetzungen von angiogeneseinhibitoren
PE20000632A1 (es) Formulaciones de ziprasidona
JP2006504776A5 (de)
WO2007005249A3 (en) Nanoparticles and dendritic-polymer-based hydrogels comprising them
NO20064282L (no) Morfolinforbindelser
BR9909189A (pt) Suspensão de agente ativo peroral
BRPI0518772A2 (pt) formulaÇÕes de benzotiofeno em nanopartÍcula
ATE406194T1 (de) Verwendung von gefüllten amphiphilen statistischen polymeren zum eindicken von riesenmizellen enthaltenden phasen und wässrige zusammensetzung davon
BRPI0401103A (pt) Composição compósita, método para formar a mesma, composição modificada, e, método para formar a mesma
BRPI0519741A2 (pt) composição de cuidado oral, e, método para clareamento de uma superfìcie de dente
ATE391163T1 (de) O/w-emulgator, o/w-emulsion und deren verwendungen
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
JP2008538751A5 (de)
DE60114115D1 (de) Bimodale polymerzusammensetzungen mit hohem Feststoffanteil, ihre Herstellung und Verwendung
WO2005003027A3 (fr) Plaquettes de phosphate de calcium nanometrique
BRPI0511574A (pt) composição, método para depositar um poliéster de açúcar sobre um substrato, e, uso de uma composição

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1438961

Country of ref document: EP